Vaxcyte, Inc.·4

Jan 4, 4:32 PM ET

Dhaliwal Harpreet S. 4

4 · Vaxcyte, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2022-12-30
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-12-30+15,00015,000 total
    Exercise: $47.95Exp: 2032-12-30Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION